Autoimmune and rheumatic diseases Sarcopenia
Conditions
Interventions
Provide BCAA-rich supplements and intervention with exercise support from a physical therapist
Sponsors
Yabe Daisuke
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients who have given their free and voluntary written consent to participate in this study after receiving full explanation and with full understanding (2) Patients aged 16 years or older, regardless of gender (3) Patients who have been diagnosed with rheumatoid/ collagen diseases and related diseases by the time of enrollment (4) Patients who were admitted to our department.
Exclusion criteria
Exclusion criteria: (1) Patients requiring urgent treatment (2) Patients undergoing treatment for malignant diseases (3) Patients with severe renal disease (4) Patients with severe hepatic disorder (5) Other patients who are judged to be inappropriate by the physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in SMI change at 4 weeks between treatment groups | — |
Secondary
| Measure | Time frame |
|---|---|
| The association will be evaluated by a linear regression model with the SMI value at 4 weeks as the objective variable and risk factors (age, BMI, and gender) as explanatory variables. | — |
Contacts
Public ContactMasami Mizuno
Division of Rheumatology and Endocrinology
Outcome results
None listed